These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. ABO Blood Grouping Mismatch in Hematopoietic Stem Cell Transplantation and Clinical Guides. Shokrgozar N; Tamaddon G Int J Hematol Oncol Stem Cell Res; 2018 Oct; 12(4):322-328. PubMed ID: 30774834 [TBL] [Abstract][Full Text] [Related]
10. Donor-to-Recipient ABO Mismatch Does Not Impact Outcomes of Allogeneic Hematopoietic Cell Transplantation Regardless of Graft Source. Damodar S; Shanley R; MacMillan M; Ustun C; Weisdorf D Biol Blood Marrow Transplant; 2017 May; 23(5):795-804. PubMed ID: 28232088 [TBL] [Abstract][Full Text] [Related]
11. Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning. Worel N; Greinix HT; Supper V; Leitner G; Mitterbauer M; Rabitsch W; Fischer G; Rosenmayr A; Höcker P; Kalhs P Transfusion; 2007 Aug; 47(8):1494-502. PubMed ID: 17655594 [TBL] [Abstract][Full Text] [Related]
12. Impact of donor-recipient major ABO mismatch on allogeneic transplantation outcome according to stem cell source. Blin N; Traineau R; Houssin S; Peffault de Latour R; Petropoulou A; Robin M; Larghero J; Ribaud P; Socié G Biol Blood Marrow Transplant; 2010 Sep; 16(9):1315-23. PubMed ID: 20353831 [TBL] [Abstract][Full Text] [Related]
13. Risk factors for readmission for hyperbilirubinemia in neonates with ABO hemolytic disease: a single-center retrospective cohort study. Xu C; Bao Y; He Y; Wu M; Zhu J J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2238106. PubMed ID: 37487760 [TBL] [Abstract][Full Text] [Related]
14. Role of Cord Blood Carboxyhemoglobin in Detecting Significant Hyperbilirubinemia in Term Neonates with ABO Alloimmunization. Tıraş M; Can E; Hamilçıkan Ş Am J Perinatol; 2022 Sep; 39(12):1321-1325. PubMed ID: 33395710 [TBL] [Abstract][Full Text] [Related]
15. The role of UGT1A1 promoter polymorphism and exon-1 mutations in neonatal jaundice. Halis H; Ergin H; Köseler A; Atalay EÖ J Matern Fetal Neonatal Med; 2017 Nov; 30(22):2658-2664. PubMed ID: 27842454 [TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn. Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442 [TBL] [Abstract][Full Text] [Related]
17. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility. Sarici SU; Yurdakök M; Serdar MA; Oran O; Erdem G; Tekinalp G; Yiğit S Pediatrics; 2002 Apr; 109(4):e53. PubMed ID: 11927726 [TBL] [Abstract][Full Text] [Related]
18. [Effect of ABO-Incompatibility on Outcome of Allogeneic Hematopoietic Stem Cell Transplantation]. Yang BB; Gan YF; Chen P; Chen Y; Yu K Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):535-540. PubMed ID: 28446307 [TBL] [Abstract][Full Text] [Related]
19. Immune haemolysis after renal transplantation secondary to ABO minor-mismatch between donor and recipient. Jayaranee S; Ramesh P; Nadesan V Singapore Med J; 2002 Aug; 43(8):421-2. PubMed ID: 12507029 [TBL] [Abstract][Full Text] [Related]
20. Bidirectional ABO Mismatch Is Associated With Elevated Mortality in Hematopoietic Stem Cell Transplantation: Insights From a Single-Center Experience. Özkan SG; Kimiaei A; Safaei S; Büyükyatıkçı AA; Sönmezoğlu M; Özkan HA Cureus; 2024 Feb; 16(2):e54847. PubMed ID: 38533156 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]